Back to search
FDAFDA · Food and drugs·Recall number D-1104-2023

All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar.

Published August 30, 2023 · Recall initiated: August 14, 2023

Summary

FDA records drug Class II recall D-1104-2023, published August 30, 2023 and initiated August 14, 2023. Recalling firm: Inmar Supply Chain Solutions, LLC; Status: Ongoing; Reported quantity: Unknown; Lot: Miscellaneous. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center. Also, due to unusually hot weather, FDA Recalled Products may have been subjected to temperatures in excess of storage condition instructions on product labeling.

What to do

Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Inmar Supply Chain Solutions, LLC
Distributor
Separate Distribution List (salvage buyers) provided by Inmar and will be uploaded. Final customer distribution unknown.
Lot
Miscellaneous
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar. recalled?

Yes. FDA published recall D-1104-2023 on August 30, 2023. Reported hazard: CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center. Also, due to unusually hot weather, FDA Recalled Products may have been subjected to temperatures in excess of storage condition instructions on product labeling.

What should I do if I have this product?

Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit